Skip to main content

ADVERTISEMENT

Jan Paul Ottervanger, MD, PhD

Original Contribution
07/06/2010
   ABSTRACT: Objective. To compare the efficacy of rapamycin-eluting stents (RES) and paclitaxel-eluting stents (PES) in patients undergo percutaneous coronary intervention. Background. RES and PES differ significantly with respect to polymer...
   ABSTRACT: Objective. To compare the efficacy of rapamycin-eluting stents (RES) and paclitaxel-eluting stents (PES) in patients undergo percutaneous coronary intervention. Background. RES and PES differ significantly with respect to polymer...
   ABSTRACT: Objective. To...
07/06/2010
Journal of Invasive Cardiology
Original Contribution
12/21/2010
Aims. Although closure devices may be comfortable for patients, the clinical benefits in patients with moderate-to-high risk of bleeding are not yet clear. We compared a closure device with manual compression in moderate- to high-risk...
Aims. Although closure devices may be comfortable for patients, the clinical benefits in patients with moderate-to-high risk of bleeding are not yet clear. We compared a closure device with manual compression in moderate- to high-risk...
Aims. Although closure devices...
12/21/2010
Journal of Invasive Cardiology
Original Contribution
02/29/2012
Abstract: Aims. The aim of this subanalysis was to assess the net clinical effect of prehospital administration of tirofiban in ST-elevation myocardial infarction (STEMI) patients with high risk of bleeding. Methods. This is a retrospective...
Abstract: Aims. The aim of this subanalysis was to assess the net clinical effect of prehospital administration of tirofiban in ST-elevation myocardial infarction (STEMI) patients with high risk of bleeding. Methods. This is a retrospective...
Abstract: Aims. The aim of this...
02/29/2012
Journal of Invasive Cardiology